🇺🇸 ChAdox1 in United States

47 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Covid-19 — 6 reports (12.77%)
  2. Back Pain — 5 reports (10.64%)
  3. Dry Skin — 5 reports (10.64%)
  4. Nasopharyngitis — 5 reports (10.64%)
  5. Pyrexia — 5 reports (10.64%)
  6. Skin Ulcer — 5 reports (10.64%)
  7. Abdominal Distension — 4 reports (8.51%)
  8. Constipation — 4 reports (8.51%)
  9. Covid-19 Pneumonia — 4 reports (8.51%)
  10. Diarrhoea — 4 reports (8.51%)

Source database →

ChAdox1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ChAdox1 approved in United States?

ChAdox1 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ChAdox1 in United States?

Makerere University is the originator. The local marketing authorisation holder may differ — check the official source linked above.